Aurora kinase inhibitors as potential anticancer agents: Recent advances

T Pradhan, O Gupta, G Singh, V Monga - European Journal of Medicinal …, 2021 - Elsevier
Aurora kinases are a family of serine/threonine kinases that play a crucial role in cell
proliferation through the regulation of mitotic spindles. These kinases are the regulatory …

Update on aurora kinase targeted therapeutics in oncology

MR Green, JE Woolery… - Expert opinion on drug …, 2011 - Taylor & Francis
Introduction: Mammalian cells contain three distinct serine/threonine protein kinases with
highly conserved catalytic domains, including aurora A and B kinases that are essential …

[HTML][HTML] ALKBH5 promotes the proliferation of renal cell carcinoma by regulating AURKB expression in an m6A-dependent manner

X Zhang, F Wang, Z Wang, X Yang, H Yu… - Annals of …, 2020 - ncbi.nlm.nih.gov
Background The modification and regulation of N6-methyladenosine (m 6 A) at mRNA level
can affect the development and progression in various tumors. ALKBH5, as an m 6 A …

SMARCA4-inactivating mutations increase sensitivity to Aurora kinase A inhibitor VX-680 in non-small cell lung cancers

V Tagal, S Wei, W Zhang, RA Brekken… - Nature …, 2017 - nature.com
Mutations in the SMARCA4/BRG1 gene resulting in complete loss of its protein (BRG1)
occur frequently in non-small cell lung cancer (NSCLC) cells. Currently, no single …

A streamlined search technology for identification of synergistic drug combinations

A Weiss, RH Berndsen, X Ding, CM Ho, PJ Dyson… - Scientific reports, 2015 - nature.com
A major key to improvement of cancer therapy is the combination of drugs. Mixing drugs that
already exist on the market may offer an attractive alternative. Here we report on a new …

Quercetin suppresses lung cancer growth by targeting Aurora B kinase

Z Xingyu, M Peijie, P Dan, W Youg, W Daojun… - Cancer …, 2016 - Wiley Online Library
Abstract aurora B kinase is highly expressed in several cancer cells and promotes
tumorigenesis and progression, and therefore, it is an important target for drug to treat …

Network analysis of immunotherapy-induced regressing tumours identifies novel synergistic drug combinations

WJ Lesterhuis, C Rinaldi, A Jones, EN Rozali… - Scientific reports, 2015 - nature.com
Cancer immunotherapy has shown impressive results, but most patients do not respond. We
hypothesized that the effector response in the tumour could be visualized as a complex …

[HTML][HTML] Tanshinones suppress AURKA through up-regulation of miR-32 expression in non-small cell lung cancer

ZL Ma, BJ Zhang, DT Wang, X Li, JL Wei, BT Zhao… - Oncotarget, 2015 - ncbi.nlm.nih.gov
Tanshinone is the liposoluble constituent of Salia miltiorrhiza, a root used in traditional
herbal medicine which is known to possess certain health benefits. Although it is known that …

RIPK1-dependent cell death: a novel target of the Aurora kinase inhibitor Tozasertib (VX-680)

S Martens, V Goossens, L Devisscher, S Hofmans… - Cell Death & …, 2018 - nature.com
Abstract The Aurora kinase family (Aurora A, B and C) are crucial regulators of several
mitotic events, including cytokinesis. Increased expression of these kinases is associated …

MK-0457, an Aurora kinase and BCR–ABL inhibitor, is active in patients with BCR–ABL T315I leukemia

FJ Giles, RT Swords, A Nagler, A Hochhaus… - Leukemia, 2013 - nature.com
MK-0457, an Aurora kinase and BCR–ABL inhibitor, was studied on a Phase I/II study in 77
patients with refractory hematologic malignancies. The average number of cycles per patient …